| Trial Identifier: | D5371C00001 |
| Sponsor: | AstraZeneca |
| NCTID:: | NCT03766399 |
| Start Date: | November 2018 |
| Primary Completion Date: | June 2021 |
| Study Completion Date: | June 2021 |
| Condition: | Asthma |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| English Version | |
| English Translation |
| Country | Location |
|---|---|
| Germany | Berlin, Germany, 14050 |
| New Zealand | Wellington, New Zealand, 6021 |
| United Kingdom | Harrow, United Kingdom, HA1 3UJ |
| United Kingdom | Manchester, United Kingdom, M23 9GP |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company